Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AmerisourceBergen Corp (NY: ABC )

143.19 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40
Open 143.19
Bid (Size) 90.00 (1)
Ask (Size) 160.00 (1)
Prev. Close 143.19
Today's Range 143.19 - 143.19
52wk Range 111.34 - 167.19
Shares Outstanding 207,787,116
Dividend Yield 1.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
The opioid crisis has raised public awareness about the dire state of pain-management options for the estimated 50 million Americans with chronic pain. 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today
AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years by 2.86% on an annualized basis producing an average annual return of 14.13%. Currently, AmerisourceBergen has a market... 
Via Benzinga

Performance

YTD
+7.97%
+7.97%
1 Month
-7.49%
-7.49%
3 Month
-7.64%
-7.64%
6 Month
+8.18%
+8.18%
1 Year
+24.80%
+24.80%

More News

Read More
Where AmerisourceBergen Stands With Analysts
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022
Via Benzinga
Analyst Ratings for AmerisourceBergen
Via Benzinga
AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
From AmerisourceBergen Corporation
Via Business Wire
AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
From AmerisourceBergen Corporation
Via Business Wire
Here's How Much You Would Have Made Owning AmerisourceBergen Stock In The Last 20 Years
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Via Benzinga
AmerisourceBergen Lifts FY22 Guidance As Q2 Earnings Beats Estimates
Via Benzinga
Fortune 500 List Includes Cryptocurrency Company For The First Time; 30 Return After Missing 2021
Via Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
Via Benzinga
AmerisourceBergen Earnings Perspective: Return On Invested Capital
Via Benzinga
Moderna And 3 Other Stocks Insiders Are Selling
Via Benzinga
Recap: AmerisourceBergen Q2 Earnings
Via Benzinga
AmerisourceBergen Provides Update on Capital Deployment
From AmerisourceBergen Corporation
Via Business Wire
What's Going On With AmerisourceBergen Shares Today
Via Benzinga
Why Cramer Recommends Buying AECOM, But Suggests Caution On Black Knight
Via Benzinga
Walgreens Announces $683M Opioid Settlement With Florida
Via Benzinga
AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
From AmerisourceBergen Corporation
Via Business Wire
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
Via Benzinga
Distributors Agree to Opioid Settlement With Washington State
From McKesson Corporation
Via Business Wire
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Via Benzinga
President Biden To Outline Strategy To Tackle Drug Addiction, Overdose: Reuters
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.